Comparable results have been described for bladder cancer where the loss of the CDH3 protein signal was associated with muscle invasiveness, high grade (G3) tumors, nodal extension, and poor clinical outcomes and prognoses with respect to long-term and overall survival [30]. Here, CDH3 is linked to urinary bladder cancer.